FLGT
Fulgent Genetics Inc
22.20$
+3.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.0% | 64.2% | 65.7% | 62.7% | 62.7% | 58.2% | 61.4% | 57.9% | 57.8% | 60.9% | 69.8% | 69.9% | 64.4% | |
| 47.0% | 35.8% | 34.3% | 37.3% | 37.3% | 41.8% | 38.6% | 42.1% | 42.2% | 39.1% | 30.2% | 30.1% | 35.6% | |
| 11.8% | 17.0% | 17.7% | 19.0% | 16.4% | 15.9% | 16.9% | 16.5% | 16.5% | 17.0% | 19.9% | 17.0% | 17.5% | |
| 20.7% | 45.0% | 33.3% | 30.0% | 29.2% | 31.9% | 34.4% | 32.3% | 27.8% | 50.0% | 38.9% | 31.8% | 37.0% | |
| 46.8% | 250.1% | 68.1% | 63.9% | 61.1% | 63.0% | 65.5% | 66.2% | 60.5% | 82.6% | 78.9% | 69.8% | 72.7% | |
| 0.3% | -214.3% | -33.8% | -26.6% | -23.8% | -21.2% | -26.9% | -24.1% | -18.3% | -43.5% | -48.7% | -39.7% | -37.1% | |
| 0.1% | 5.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.1% | 0.1% | |
| 8.1% | -205.9% | -22.0% | -15.8% | -25.8% | -10.6% | -16.0% | -26.3% | -7.3% | -35.1% | -36.5% | -34.8% | -28.1% | |
| 24.0% | -15.4% | -0.5% | -3.0% | -5.3% | -2.4% | 0.2% | -2.8% | 0.8% | -6.7% | -1.0% | 0.0% | -1.7% | |
| -15.5% | -181.8% | -20.9% | -12.3% | -20.4% | -7.7% | -15.7% | -23.2% | -7.9% | -28.1% | -34.9% | -34.6% | -26.0% | |
| 15.8% | -34.5% | -11.6% | -7.1% | -17.6% | -2.2% | -7.9% | -18.9% | -0.1% | -27.6% | -28.1% | -25.7% | -20.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.